710 related articles for article (PubMed ID: 17635595)
1. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
2. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes JL; Smith T; Diamond M; Ames MH
Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
[TBL] [Abstract][Full Text] [Related]
3. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral naratriptan in the treatment of menstrually related migraine.
Massiou H; Jamin C; Hinzelin G; Bidaut-Mazel C;
Eur J Neurol; 2005 Oct; 12(10):774-81. PubMed ID: 16190915
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
7. Naratriptan in the short-term prophylaxis of pure menstrual migraine.
Moschiano F; Allais G; Grazzi L; Usai S; Benedetto C; D'Amico D; Roncolato M; Bussone G
Neurol Sci; 2005 May; 26 Suppl 2():s162-6. PubMed ID: 15926020
[TBL] [Abstract][Full Text] [Related]
8. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Silberstein SD; Elkind AH; Schreiber C; Keywood C
Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
[TBL] [Abstract][Full Text] [Related]
11. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
Headache; 1997; 37(10):640-5. PubMed ID: 9439085
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group.
Heywood J; Bomhof MA; Pradalier A; Thaventhiran L; Winter P; Hassani H
Cephalalgia; 2000 Jun; 20(5):470-4. PubMed ID: 11037743
[TBL] [Abstract][Full Text] [Related]
13. Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
Sheftell FD; Rapoport AM; Tepper SJ; Bigal ME
Headache; 2005; 45(10):1400-6. PubMed ID: 16324173
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.
Havanka H; Dahlöf C; Pop PH; Diener HC; Winter P; Whitehouse H; Hassani H
Clin Ther; 2000 Aug; 22(8):970-80. PubMed ID: 10972633
[TBL] [Abstract][Full Text] [Related]
16. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
Mathew NT; Asgharnejad M; Peykamian M; Laurenza A
Neurology; 1997 Dec; 49(6):1485-90. PubMed ID: 9409334
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
[TBL] [Abstract][Full Text] [Related]
18. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Silberstein SD; Berner T; Tobin J; Xiang Q; Campbell JC
Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
[TBL] [Abstract][Full Text] [Related]
19. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
20. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
